Back
Novo Nordisk A/S Vs. Amgen, Inc. Industry Stock Comparison
Sell
33
NVO
Novo Nordisk A/S
Last Price:
$50.87
Seasonality Move:
3.96%
Sell
31
AMGN
Amgen, Inc.
Last Price:
$327.34
Seasonality Move:
6.61%
Sell
33
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $51.22. The Score for NVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Amgen, Inc. (AMGN)
is a Sell
Is Amgen, Inc. a Buy, Sell or Hold?
-
The current Amgen, Inc. [AMGN] share price is $327.31. The Score for AMGN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
AMGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $51.22The current trend is moderately bullish and NVO is experiencing slight selling pressure.
AMGN Stock Price Chart
What is Amgen, Inc.'s stock price today?
-
The Amgen, Inc. share price today is $327.31The current trend is moderately bearish and AMGN is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 56.53 | Buy |
| Chaikin Money Flow: | -5803708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 49.74 | Sell |
| Chaikin Money Flow: | -1126932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (321.13 - 339.13) | Sell |
| Bollinger Bands (100): | (282.92 - 327.66) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.38 | Buy |
| 20-day SMA: | 49.18 | Buy |
| 50-day SMA: | 49.38 | Buy |
| 200-day SMA: | 60.05 | Sell |
| 8-day EMA: | 50.78 | Buy |
| 20-day EMA: | 49.79 | Buy |
| 50-day EMA: | 50.45 | Buy |
| 200-day EMA: | 62.41 | Sell |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 330.35 | Sell |
| 20-day SMA: | 327.32 | Sell |
| 50-day SMA: | 323.13 | Buy |
| 200-day SMA: | 297.72 | Buy |
| 8-day EMA: | 329.09 | Sell |
| 20-day EMA: | 328.48 | Sell |
| 50-day EMA: | 322.08 | Buy |
| 200-day EMA: | 304.09 | Buy |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.37 per share.
Amgen, Inc. Earnings Growth & AMGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.69 per share.
Novo Nordisk A/S Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||